Loop | Achim Aigner
Accommodation – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich
Leipziger Pharmakologen forschen an Molekülen gegen Prostatakrebs
European Technology Platform on Nanomedicine
Drug Delivery by Ultrasound-Responsive Nanocarriers for Cancer Treatment
Influence of nanoparticle-mediated transfection on proliferation of primary immune cells in vitro and in vivo | PLOS ONE
SATB1 as oncogenic driver and potential therapeutic target in head & neck squamous cell carcinoma (HNSCC) | Scientific Reports
Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo: Molecular Therapy - Nucleic Acids
SATB1-Mediated Upregulation of the Oncogenic Receptor Tyrosine Kinase HER3 Antagonizes MET Inhibition in Gastric Cancer Cells
Zeitschrift für Naturforschung C
Evaluation of Colon-Specific Plasma Nanovesicles as New Markers of Colorectal Cancer
Cell-type specific and non-redundant anti-proliferative effects of shRNA-mediated Galpha12- and Galpha13 knockdown in lung canc
Functional Role and Therapeutic Potential of the Pim-1 Kinase in Colon Carcinoma
Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma
Tau Silencing by siRNA in the P301S Mouse Model of Tauopathy
Therapeutic siRNA: State-of-the-Art and Future Perspectives | SpringerLink
Focused Ultrasound Therapy
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Mitarbeiter des Rudolf-Boehm-Institutes
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma
Front Cover: Balancing Histone Deacetylase (HDAC) Inhibition and Drug‐likeness: Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors (ChemMedChem 9/2022) - Schäker‐Hübner - 2022 - ChemMedChem - Wiley Online Library
فلسفي دافئ تحويلات بند تشابه لفة aigner et al 2011 - afsassociation.org
Silencing of Neuropilins and GIPC1 in pancreatic ductal adenocarcinoma exerts multiple cellular and molecular antitumor effects | Scientific Reports
